StreetInsider.com News Articles

UBS Starts Caris Life Sciences Inc (CAI) at Neutral

Wed, 09 Sep 2026 06:08:33 -0400

UBS analyst Douglas Schenkel initiates coverage on Caris Life Sciences Inc (NASDAQ: CAI) with a Neutral rating and a price target of $28.00.

For an analyst ratings summary and ratings history on Caris Life Sciences Inc click here. For more ratings news on Caris Life Sciences Inc click here.

Shares of Caris Life Sciences Inc closed at $24.82 yesterday.

Caris Life Sciences Inc (CAI) PT Raised to $29 at Baird

Thu, 03 Sep 2026 07:05:49 -0400

Baird analyst Catherine Schulte raised the price target on Caris Life Sciences Inc (NASDAQ: CAI) to $29.00 (from $23.00) while maintaining a Outperform rating.

Caris Life Sciences publishes AI therapy study for pancreatic cancer

Thu, 27 Aug 2026 08:31:06 -0400

Caris Life Sciences (NASDAQ: CAI) announced the publication of a study in npj Precision Oncology describing an AI-driven approach to optimize first-line treatment selection in pancreatic cancer, according to a company press release.

The study examines the performance of Caris AI Insights, an AI-based molecular signature tool designed to predict first-line treatment benefit. In the testing cohort, standard molecular risk patients predicted to benefit from FOLFIRINOX achieved a median overall survival of 16.0 months when treated with that regimen, compared with 9.9 months for those treated with gemcitabine plus nab-paclitaxel. The study found that approximately half of patients received a different

Caris Life Sciences publishes AI therapy study for pancreatic cancer

Thu, 27 Aug 2026 08:31:06 -0400

Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer

Thu, 27 Aug 2026 08:30:00 -0400

Caris AI Insights for pancreatic cancer is proprietary, only available to Caris Life Sciences customers and not achievable through small panels

IRVING, Texas, Aug. 27, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading TechBio company, today announced the publication of a study in npj Precision Oncology describing the development and validation of an AI-driven approach to optimize first-line treatment selection in pancreatic cancer, advancing a more personalized care path for one of the deadliest malignancies.

Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer

Thu, 27 Aug 2026 08:30:00 -0400

Caris AI Insights for pancreatic cancer is proprietary, only available to Caris Life Sciences customers and not achievable through small panels

Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer

Thu, 27 Aug 2026 08:30:00 -0400

Caris AI Insights for pancreatic cancer is proprietary, only available to Caris Life Sciences customers and not achievable through small panels

Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer

Thu, 27 Aug 2026 08:30:00 -0400

Caris AI Insights for pancreatic cancer is proprietary, only available to Caris Life Sciences customers and not achievable through small panels

Form 144 Caris Life Sciences, Filed by: POSTE GEORGE

Mon, 24 Aug 2026 16:29:00 -0400

si-local-file:///var/storage/secattach/20260824/26968458.html

Form 144 Caris Life Sciences, Filed by: POSTE GEORGE

Mon, 24 Aug 2026 16:29:00 -0400

si-local-file:///var/storage/secattach/20260824/26968458.html

Form 4 Caris Life Sciences, For: Aug 14 Filed by: CASTLEMAN PETER M

Fri, 14 Aug 2026 17:45:00 -0400

si-local-file:///var/storage/secattach/20260814/26933025.html

Form 4 Caris Life Sciences, For: Aug 14 Filed by: CASTLEMAN PETER M

Fri, 14 Aug 2026 17:45:00 -0400

si-local-file:///var/storage/secattach/20260814/26933025.html

Form 4 Caris Life Sciences, For: Aug 14 Filed by: PHILLIPS T DANNY

Fri, 14 Aug 2026 17:44:00 -0400

si-local-file:///var/storage/secattach/20260814/26933019.html

Form 4 Caris Life Sciences, For: Aug 14 Filed by: PHILLIPS T DANNY

Fri, 14 Aug 2026 17:44:00 -0400

si-local-file:///var/storage/secattach/20260814/26933019.html

Form 4 Caris Life Sciences, For: Aug 14 Filed by: Minor Lloyd

Fri, 14 Aug 2026 17:43:00 -0400

si-local-file:///var/storage/secattach/20260814/26933010.html

Form 4 Caris Life Sciences, For: Aug 14 Filed by: Minor Lloyd

Fri, 14 Aug 2026 17:43:00 -0400

si-local-file:///var/storage/secattach/20260814/26933010.html

Form 4 Caris Life Sciences, For: Aug 14 Filed by: Gilliam Joseph E

Fri, 14 Aug 2026 17:42:00 -0400

si-local-file:///var/storage/secattach/20260814/26933009.html

Form 4 Caris Life Sciences, For: Aug 14 Filed by: Gilliam Joseph E

Fri, 14 Aug 2026 17:42:00 -0400

si-local-file:///var/storage/secattach/20260814/26933009.html

Form 4 Caris Life Sciences, For: Aug 14 Filed by: Vacirca Jeff L

Fri, 14 Aug 2026 17:41:00 -0400

si-local-file:///var/storage/secattach/20260814/26933005.html

Form 4 Caris Life Sciences, For: Aug 14 Filed by: Vacirca Jeff L

Fri, 14 Aug 2026 17:41:00 -0400

si-local-file:///var/storage/secattach/20260814/26933005.html

Form 4 Caris Life Sciences, For: Aug 14 Filed by: Fredrickson David Paul

Fri, 14 Aug 2026 17:41:00 -0400

si-local-file:///var/storage/secattach/20260814/26933007.html

Form 4 Caris Life Sciences, For: Aug 14 Filed by: Fredrickson David Paul

Fri, 14 Aug 2026 17:41:00 -0400

si-local-file:///var/storage/secattach/20260814/26933007.html

Form 4 Caris Life Sciences, For: Aug 14 Filed by: JOHANSEN LAURA I

Fri, 14 Aug 2026 17:40:00 -0400

si-local-file:///var/storage/secattach/20260814/26933004.html

Form 4 Caris Life Sciences, For: Aug 14 Filed by: JOHANSEN LAURA I

Fri, 14 Aug 2026 17:40:00 -0400

si-local-file:///var/storage/secattach/20260814/26933004.html

Form 4 Caris Life Sciences, For: Aug 14 Filed by: HALBERT JON

Fri, 14 Aug 2026 17:39:00 -0400

si-local-file:///var/storage/secattach/20260814/26932998.html